# MedTex Ventures

> MedTex Ventures is a VC fund in Norwalk backing Medical Device, Medical and Health Care. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Norwalk, United States
- Total investments: 7
- Last investment: Oct 2022
- Lead investor: 43%
- Last updated: Aug 2026

MedTex Ventures is a venture capital firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical Device | 3 | 43% |
| Medical | 2 | 29% |
| Health Care | 2 | 29% |
| Biotechnology | 2 | 29% |
| Analytics | 1 | 14% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 43% |
| Series B | 1 | 14% |
| Series C | 1 | 14% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 3 | 43% |
| United Kingdom | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Axis Spine Technologies | Axis Spine Technologies is building an expert team to develop highly differentiated products that provide meaningful improvements in patient care. | $12.5M | Series A | Oct 18, 2022 |  |
| Levita Magnetics | As a medical device start up, Levita Magnetics is passionate about developing innovative magnetic surgical platforms that serve as a catalyst in the continued evolution of less invasive surgery.The company's mission is to enhance patient outcomes by minimizing the footprint of surgical procedures across multiple indications and broadpatient populations. It's innovative magnetic surgical platform, called Magnetic Surgery®, is the next step in the evolution of less invasive surgery. | $26M | Series C | Aug 11, 2022 |  |
| Elucid | Based in the Boston biotech and medtech hub, Elucid is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, ElucidVivo, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from asingle CTA to inform risk of event (heart attack or stroke) & treatment selection. Additionally, Elucid works with pharmaceutical companies, providers, and research organizations to provide quantitative image analysis services. | $27M | Series B | Jun 22, 2022 |  |
| Elucid | Based in the Boston biotech and medtech hub, Elucid is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, ElucidVivo, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from asingle CTA to inform risk of event (heart attack or stroke) & treatment selection. Additionally, Elucid works with pharmaceutical companies, providers, and research organizations to provide quantitative image analysis services. | $27M | Series B | Jun 22, 2022 |  |
| Ictero Medical | Ictero Medical is a medical devices company that specializes in helps definitive treatment option for patients. | $6M | Series A | Apr 29, 2022 |  |
| Ictero Medical | Ictero Medical is a medical devices company that specializes in helps definitive treatment option for patients. | $6M | Series A | Dec 12, 2021 |  |
| Elucid | Based in the Boston biotech and medtech hub, Elucid is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, ElucidVivo, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from asingle CTA to inform risk of event (heart attack or stroke) & treatment selection. Additionally, Elucid works with pharmaceutical companies, providers, and research organizations to provide quantitative image analysis services. | $10M | Series A | May 10, 2021 |  |

7 of 7 investments shown.

## Co-investors
- [BlueStone Venture Partners](https://shizune.co/investors/profile/bluestone-venture-partners) — VC Fund, 3 deals together
- [IAG Capital Partners](https://shizune.co/investors/profile/iag-capital-partners) — VC Fund, 3 deals together
- [S3 Ventures](https://shizune.co/investors/profile/s3-ventures) — VC Fund, 3 deals together
- [Aphelion Capital](https://shizune.co/investors/profile/aphelion-capital) — VC Fund, 2 deals together
- [Biovision Ventures](https://shizune.co/investors/profile/biovision-ventures) — VC Fund, 2 deals together
- Bold Brain Ventures — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does MedTex Ventures invest in?

MedTex Ventures invests primarily in Medical Device, Medical and Health Care startups, most often at Series A and Series B stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did MedTex Ventures last invest?

The most recent investment recorded for MedTex Ventures closed in Oct 2022. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co